# OnCo record ivb003 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ivb003/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ivb003" ;
  schema:name "IVB003"@en ;
  schema:alternateName "IVB-003"@en, "transmucosal tocotrienols"@en ;
  schema:description "IVB003 is an experimental vitamin E compound, taken under the tongue, that Invictus Therapeutics plans to test alongside standard treatment in advanced pancreatic cancer. Whether it helps is not known."@en ;
  schema:url <https://onco.cc/drugs/ivb003/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://abnnewswire.net/press/en/122891/VGI-Health-Technology-Limited-(NSX-VTL)-HREC-Approval-for-Phase-II-Clinical-Study.html> ;
  onco:status "planned" ;
  onco:modality "Tocotrienols (a form of vitamin E) dissolved under the tongue; molecular form not stated" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:companies <https://onco.cc/companies/invictus-therapeutics/> .
